| MID PTGA P value, univariate | MID Pain P value, univariate | MID MDGA P value, univariate | MID HAQ P value, univariate | MID skin score P value, univariate |
Disease duration, years (SD) | 0.849 | 0.150 | 0.440 | 0.823 | 0.542 |
Age, years (SD) | 0.101 | 0.607 | 0.294 | 0.473 | 0.291 |
PTGA overall health (SD) | <0.001 | 0.001 | 0.346 | 0.001 | 0.943 |
PTGA pain (SD) | 0.023 | <0.001 | 0.497 | 0.010 | 0.417 |
MDGA overall health (SD) | 0.129 | 0.198 | <0.001 | 0.209 | 0.202 |
HAQ (SD) | 0.072 | 0.004 | 0.036 | <0.001 | 0.194 |
Skin score (SD) | 0.721 | 0.558 | 0.016 | 0.113 | 0.004 |
ESR in mm/hr | 0.358 | 0.163 | 0.107 | 0.631 | 0.988 |
CRP in mg/L (SD) | 0.081 | 0.028 | 0.059 | 0.308 | 0.690 |
TLC % predicted (SD) | 0.260 | 0.436 | 0.971 | 0.016 | 0.674 |
FVC % predicted (SD) | 0.754 | 0.716 | 0.642 | 0.012 | 0.905 |
DLCO % predicted (SD) | 0.151 | 0.197 | 0.531 | 0.554 | 0.184 |
Female gender (%) | 0.965 | 0.954 | 0.093 | 0.792 | 0.994 |
Current smoker (%) | 0.031 | 0.963 | 0.257 | 0.736 | 0.718 |
Post secondary education (%) | 0.097 | 0.586 | 0.976 | 0.584 | 0.105 |
Treatment type | 0.038 | 0.883 | 0.560 | 0.025 | 0.899 |